ACARIX A/S

The Company's principal activitiesAcarix is transforming early cardiac diagnostics with the CADScor® System, an innovative, non-invasive, and radiation-free technology designed to rapidly and accurately rule out coronary artery disease (CAD) at the point of care. The system supports clinicians in evaluating patients experiencing symptoms such as non-acute chest pain or shortness of breath by utilizing advanced acoustic analysis to assess coronary blood flow, arterial compliance, and heart rhythm. By generating a patient specific CAD-score that incorporates clinical risk factors including age, gender, and hypertension, the CADScor System enables risk stratification while helping reduce unnecessary, invasive, and costly diagnostic procedures.